TITLE

Patents facilitation centre opened

PUB. DATE
September 2008
SOURCE
Chemical Business;Sep2008, Vol. 22 Issue 9, p63
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the inauguration of the Intellectual Property Rights (IPRs) and Patents Facilitation Centre in Hyderabad, India by the Pharmaceuticals Export Promotion Council (Pharmexcil) in 2008. The Department of Chemicals & Petrochemicals is supporting the establishment of the centres in Mumbai and Delhi. The aim of the centre is to provide small and medium pharmaceutical manufacturers and exporters information and knowledge on patents of pharmaceutical products as opposed to other countries.
ACCESSION #
34882448

 

Related Articles

  • New Department of Pharmaceuticals formed.  // Chemical Business;Jul2008, Vol. 22 Issue 7, p69 

    The article reports on a new department which was formed by the Indian government under the Ministry of Fertilisers, Chemicals and Petrochemicals. Accordingly, it will solely look after the pharmaceutical sector which is being handled by the Department of Chemicals and Petrochemicals. Many...

  • Plan mooted for 5 new pharma institutes.  // Chemical Business;Aug2006, Vol. 20 Issue 8, p63 

    The article reports on the funds obtained by the Indian Department of Chemicals and Petrochemicals from the Planning Commission for the establishment of five pharmaceutical institutes patterned on the National Institute of Pharmaceutical Education and Research. The institutes will provide...

  • Whose Property Is It, Anyway?  // European Pharmaceutical Executive;May/Jun2006, p18 

    The article discusses the need for the pharmaceutical industry to change its attitude towards intellectual property to survive the changing climate of patent rights in Europe. It focuses on the issue of whether the possession of a single patent was sufficient grounds to bring someone else's...

  • Domestic Patents - Questions You Should Ask Your Patent Attorney. Pershes, Robert; Wagner, Louis // BioPharm International;Aug2005, Vol. 18 Issue 8, p10 

    Explores the steps in seeking and managing a patent for pharmaceutical products in the U.S. Assessment on the suitability of a drug discovery to be patented; Consideration of the free use provisions of the teachings and protection contained in the patent; Factor posing literal infringement of...

  • Pharmaceuticals and intellectual property rights: A political economy of the recent policy changes across the developing world and in Turkey. Vural, ─░pek Eren // Middle East Technical University Studies in Development;Dec2007, Vol. 34 Issue 2, p337 

    This paper explores the sources of the recent policy changes from weaker to stronger intellectual property regimes (IPRs) for pharmaceuticals across the developing world, and in Turkey. Analysing the policy change from a political economy approach, the paper argues that the increased structural...

  • Demystifying the Patent Reform Act and its Impact on Company IP Strategy. Gay, David A.; Gaede, William // BioPharm International;Jan2007, Vol. 20 Issue 1, p34 

    The article comments on the proposed Patent Reform Act of 2005 in the United States. The Act stems from reports by the Federal Trade Commission and the National Academies of Sciences which address a need to improve the efficiency and quality of the system. The article examines the impact of the...

  • The patentability of medicinal inventions related to personalized medicine in Japan. Shimbo, Itsuki; Cobden, Andrew; Sumikura, Koichi // Nature Biotechnology;Nov2005, Vol. 23 Issue 11, p1367 

    Reports on the several amendments of the examination guidelines for medicinal inventions in Japan. Possibility of obtaining a patent for a medicinal innovation by specifying the class of patients; Protection of the combinations of medicines and optimization of dosage and frequency of...

  • A HARD PILL TO SWALLOW: DOES SCHERING V. GENEVA ENDANGER INNOVATION WITHIN THE PHARMACEUTICAL INDUSTRY? De La Rosa, Alfredo // Columbia Science & Technology Law Review;2008, Vol. 9, p37 

    Recently the Federal Circuit has adopted a sweeping new rule of inherent anticipation that essentially bars the patenting of metabolites and other biological degradations of chemical compounds. This new rule, adopted in Schering v. Geneva, could substantially affect both the willingness and the...

  • Pharma patents: India ranks second.  // Siliconindia;Sep2005, Vol. 9 Issue 8, p15 

    Reports on the increasing number of applications for patent of pharmaceutical products in India. Invention of critical life saving drugs by the pharmaceutical companies; Launch of drugs at a frenetic pace in Western countries; Attraction of international attention by the pharmaceutical firms...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics